Century Therapeutics, Inc. (IPSC) stock
IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.65+0.02 (+1.23%)
Close on Nov 13, 2026Market cap $298.77MP/E –Yield –
Century Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Century Therapeutics's price to book ratio was 1.4× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.2× to 2.1×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.4× | +0.9 |
| 2025 | Dec 31, 2025 | 0.5× | +0.1 |
| 2024 | Dec 31, 2024 | 0.4× | −0.5 |
| 2023 | Dec 29, 2023 | 0.9× | −0.0 |
| 2022 | Dec 30, 2022 | 0.9× | −1.1 |
| 2021 | Dec 31, 2021 | 2.0× | – |
See a number that looks wrong?